BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19839953)

  • 1. Treatment of acute pulmonary haemorrhage in extremely preterm infants with recombinant activated factor VII.
    Poralla C; Hertfelder HJ; Oldenburg J; Müller A; Bartmann P; Heep A
    Acta Paediatr; 2010 Feb; 99(2):298-300. PubMed ID: 19839953
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant.
    Cetin H; Yalaz M; Akisu M; Karapinar DY; Kavakli K; Kultursay N
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):213-6. PubMed ID: 16575260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants.
    Olomu N; Kulkarni R; Manco-Johnson M
    J Perinatol; 2002 Dec; 22(8):672-4. PubMed ID: 12478454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of recombinant activated factor VII in diffuse alveolar haemorrhage].
    Dabar G; Harmouche C; Jammal M
    Rev Mal Respir; 2011 Jan; 28(1):106-11. PubMed ID: 21277485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: a potential role for recombinant factor VIIa.
    Filan PM; Mills JF; Clarnette TD; Ekert H; Ekert P
    J Pediatr; 2005 Dec; 147(6):857-9. PubMed ID: 16356448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant activated factor seven in acute life-threatening bleeding in neonates: report on three cases and review of literature.
    Hünseler C; Kribs A; Eifinger F; Roth B
    J Perinatol; 2006 Nov; 26(11):706-13. PubMed ID: 17066067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant factor VIIa use following massive pulmonary hemorrhage after CPB.
    Courtney H
    Paediatr Anaesth; 2009 Mar; 19(3):272. PubMed ID: 19236650
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of life-threatening bleeding in obstetrics and gynaecology --NovoSeven (recombinant factor VIIa)].
    Nikolov A; Dimitrov A; Tanchev S; Platikanov V; Nacheva A; Gateva Zh; Gerganova A
    Akush Ginekol (Sofiia); 2005; 44(5):39-44. PubMed ID: 16313053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study.
    Cosar H; Isik H; Cakır SC; Yar N; Goksen B; Tokbay H; Kertmen H; Erdoğan N; Durak I
    Paediatr Drugs; 2017 Feb; 19(1):53-58. PubMed ID: 27826851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic effect of recombinant factor VIIa with congenital factor VII deficiency.
    Karimi M; Shafieian R
    Haemophilia; 2008 Jul; 14(4):851-2. PubMed ID: 18399984
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recombinant activated factor VIIa in massive hemorrhage].
    Ingerslev J
    Ugeskr Laeger; 2005 Jun; 167(25-31):2737. PubMed ID: 16014254
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraventricular haemorrhage in preterm infants--can we improve outcome by addressing coagulation?
    Kuperman AA; Brenner B; Kenet G
    J Matern Fetal Neonatal Med; 2015 Nov; 28 Suppl 1():2265-7. PubMed ID: 23968273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
    Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
    J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of thrombocytopenia and bleeding tendency in a preterm neonate with recombinant activated factor VII: case report.
    Jakobović J; Butković D; Popović L; Bartolek D; Stanojević M; Barcot Z
    Acta Clin Croat; 2010 Sep; 49(3):309-13. PubMed ID: 21462821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label use of recombinant activated factor VII--safe or not safe?
    Aledort LM
    N Engl J Med; 2010 Nov; 363(19):1853-4. PubMed ID: 21047230
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant activated factor VII--"lifesaving or surgeon correcting"?
    Koci J; Dedek T; Havel E; Trlica J
    J Trauma; 2011 Feb; 70(2):523-4; author reply 524-5. PubMed ID: 21307759
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy.
    Chuansumrit A; Nuntnarumit P; Okascharoen C; Teeraratkul S; Suwansingh S; Supapannachart S
    Pediatrics; 2002 Jul; 110(1 Pt 1):169-71. PubMed ID: 12093965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recombinant activated Factor VII (Novo Seven) for uncontrollable hemorrhage in critically ill patients with multiple injuries].
    Pernazza F; Olearis A
    Minerva Chir; 2004 Apr; 59(2):XVII-XIX. PubMed ID: 15455479
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant factor VIIa: a universal hemostatic agent?
    Lloyd JV; Joist JH
    Curr Hematol Rep; 2002 Sep; 1(1):19-26. PubMed ID: 12901121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.